➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Medtronic
Merck
McKesson
Harvard Business School

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

SULFACETAMIDE SODIUM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for sulfacetamide sodium and what is the scope of freedom to operate?

Sulfacetamide sodium is the generic ingredient in seventeen branded drugs marketed by Bausch, Fougera Pharms, Perrigo Co Tennessee, Taro, Allergan, Alcon, Schering, Pharmafair, Miza Pharms Usa, Akorn, Sola Barnes Hind, Novartis, Optopics, Alcon Pharms Ltd, Bausch And Lomb, and Sandoz Inc, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for sulfacetamide sodium. Fourteen suppliers are listed for this compound.

Recent Clinical Trials for SULFACETAMIDE SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityN/A

See all SULFACETAMIDE SODIUM clinical trials

Pharmacology for SULFACETAMIDE SODIUM
Medical Subject Heading (MeSH) Categories for SULFACETAMIDE SODIUM

US Patents and Regulatory Information for SULFACETAMIDE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind SODIUM SULFACETAMIDE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 084146-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Akorn SODIUM SULFACETAMIDE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 083021-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Alcon CETAMIDE sulfacetamide sodium OINTMENT;OPHTHALMIC 080021-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bausch KLARON sulfacetamide sodium LOTION;TOPICAL 019931-001 Dec 23, 1996 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmafair SULFAIR 10 sulfacetamide sodium OINTMENT;OPHTHALMIC 088000-001 Dec 22, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmafair SULFAIR FORTE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 088385-001 Oct 13, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Allergan BLEPH-10 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080028-001 Approved Prior to Jan 1, 1982 AT RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Boehringer Ingelheim
Mallinckrodt
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.